YLL065W is a gene designation in Saccharomyces cerevisiae (budding yeast), encoding a protein of uncharacterized function. Research involving the "YLL065W antibody" typically refers to antibodies used to study interactions or regulatory mechanisms associated with this gene product. Notably, studies have utilized chromatin immunoprecipitation (ChIP) with antibodies targeting histone variants like Htz1 (H2A.Z) to investigate YLL065W’s promoter activity and chromatin dynamics .
In a study analyzing chromatin organization, an anti-Htz1 antibody was employed to assess Htz1 (histone variant H2A.Z) association with the promoter regions of several yeast genes, including YLL065W . Key findings include:
| Gene | Htz1 Association (% Input DNA) | Experimental Condition |
|---|---|---|
| YLL065W | 0.155% ± 0.032 | Wild-type cells on glucose media |
| GAL1 | 0.320% ± 0.045 | Wild-type cells on galactose media |
This demonstrated that Htz1 occupancy at the YLL065W promoter is context-dependent and influenced by metabolic conditions .
Quantitative RT-PCR analysis in arp6Δ and htz1Δ mutants revealed altered expression levels of YLL065W compared to wild-type strains :
| Strain | YLL065W Expression (Relative to ACT1) |
|---|---|
| Wild-type | 1.00 ± 0.12 |
| arp6Δ | 0.45 ± 0.08 |
| htz1Δ | 0.32 ± 0.06 |
These data suggest that Htz1 and the chromatin remodeler Arp6 play roles in modulating YLL065W transcription .
The reproducibility of antibody-based assays is critical. For example, the anti-Htz1 antibody used in these studies showed:
Neutralization Concordance: Binding assays (ELISA) and functional assays (ChIP) exhibited strong correlation (ρ > 0.9) .
While the anti-Htz1 antibody proved reliable in these studies, broader issues in antibody validation persist. For instance, a 2023 study found that ~12 publications per protein target included data from antibodies that failed specificity tests . This underscores the importance of rigorous validation, particularly for antibodies targeting less-characterized genes like YLL065W.
Further research is needed to:
Clarify the biological function of the YLL065W gene product.
Develop isoform-specific antibodies if YLL065W has splice variants.
Expand ChIP-seq datasets to map histone modifications across diverse growth conditions.
YLL065W is a systematic designation for a gene in Saccharomyces cerevisiae involved in silent chromatin assembly. The protein encoded by this gene is part of the Sir protein complex that mediates transcriptional silencing through interactions with nucleosomes. Understanding these interactions is fundamental to chromatin biology research and has implications for epigenetic regulation across species. The Sir protein complexes bind cooperatively to nucleosomes, and antibodies against YLL065W provide valuable tools for investigating these mechanisms .
YLL065W antibodies are primarily utilized in several key experimental techniques:
Western blotting: For detecting and quantifying YLL065W protein in yeast cell extracts
Chromatin immunoprecipitation (ChIP): To identify genomic regions where YLL065W binds
Immunofluorescence: To visualize the subcellular localization of YLL065W
Co-immunoprecipitation: To identify protein interaction partners
ChIP-seq: For genome-wide profiling of YLL065W binding sites
Thorough validation is essential before incorporating YLL065W antibodies into your research:
Specificity testing: Confirm antibody specificity using western blots with wild-type yeast and YLL065W deletion strains
Cross-reactivity assessment: Test against related Sir proteins to ensure specificity
Epitope verification: Determine if the antibody recognizes native, denatured, or both forms of the protein
Batch consistency evaluation: Compare multiple lots if available
Literature validation: Review published applications similar to your planned experiments
For effective immunodetection of YLL065W in chromatin contexts:
Cross-linking fixation: 1% formaldehyde for 15-20 minutes works effectively for most chromatin proteins
Native extraction buffers: For co-IP applications, use gentle non-ionic detergents (0.1% NP-40 or Triton X-100)
Chromatin extraction: Include DNase treatment when studying protein-chromatin interactions
Preservation of post-translational modifications: Add appropriate phosphatase and deacetylase inhibitors
Temperature considerations: Maintain samples at 4°C during extraction to preserve protein-protein interactions
ChIP optimization for YLL065W should address:
Crosslinking conditions: 1% formaldehyde for 15 minutes is standard, but may require optimization
Sonication parameters: Adjust to achieve 200-500bp chromatin fragments
Antibody concentration: Typical range is 2-5μg per ChIP reaction, requiring titration
Washing stringency: Balance between reducing background and maintaining specific interactions
Elution conditions: Optimize based on antibody-epitope binding characteristics
Controls: Include mock immunoprecipitation and non-specific antibody controls
Validation: Confirm enrichment at known binding sites using qPCR before proceeding to sequencing
Key challenges include:
Complex composition heterogeneity: Sir protein complexes can vary in composition across genomic locations
Cooperative binding effects: Sir proteins bind cooperatively, complicating interpretation of individual protein signals
Epitope masking: Interactions with other proteins may obscure antibody recognition sites
Cross-reactivity concerns: Similarity between Sir family proteins can lead to non-specific signals
Cell cycle variability: Binding patterns may change throughout the cell cycle
Technical artifacts: Distinguish between true binding and experimental artifacts through rigorous controls
For improving signal quality:
Antibody concentration optimization: Titrate to determine optimal concentration
Extended incubation times: Try overnight primary antibody incubation at 4°C
Epitope retrieval methods: Test different antigen retrieval approaches if applicable
Signal amplification systems: Consider biotin-streptavidin or tyramine amplification
Sample preparation refinement: Optimize lysis conditions to improve protein extraction
Detection system sensitivity: Switch to more sensitive detection methods if needed
Methods to verify binding specificity include:
Knockout/knockdown controls: Test the antibody in YLL065W deletion strains
Peptide competition assays: Pre-incubate antibody with purified peptide/protein
Multiple antibodies approach: Use antibodies targeting different epitopes
Gradient analysis: Analyze signal across a concentration gradient
Cross-validation: Compare results using different experimental techniques
Negative control regions: For ChIP, include regions not expected to bind YLL065W
For maintaining experimental consistency:
Reference sample testing: Keep a standardized sample for testing each new lot
Calibration curves: Generate standard curves for quantitative comparisons
Multiple lot comparison: Run side-by-side tests of old and new lots
Epitope verification: Confirm recognition of the same epitope across lots
Documentation practices: Maintain detailed records of lot numbers and validation results
Bulk purchasing: Secure multiple vials from the same lot for long-term studies
Advanced applications include:
Sequential ChIP (Re-ChIP): To study co-occupancy with other Sir proteins
Proximity ligation assays: To visualize and quantify protein-protein interactions in situ
ChIP-exo/ChIP-nexus: For high-resolution mapping of binding sites
Quantitative approaches: Use calibrated ChIP-qPCR to measure relative occupancy
Real-time binding studies: Combine with live-cell imaging techniques
Comparison across mutants: Analyze binding patterns in different genetic backgrounds
When facing contradictory results:
Technical variation assessment: Systematically evaluate all experimental variables
Biological heterogeneity analysis: Consider strain differences and growth conditions
Antibody characterization revisit: Re-validate antibody specificity and sensitivity
Alternative epitope targeting: Test antibodies recognizing different protein regions
Method triangulation: Apply multiple independent techniques
Statistical rigor enhancement: Increase replication and apply appropriate statistical tests
Expert consultation: Confer with researchers experienced with the specific protein
Antibody modifications for advanced applications:
Conjugation strategies: Direct labeling with fluorophores, enzymes, or biotin
Fragment preparation: Generate Fab or F(ab')₂ fragments for applications requiring smaller probes
Surface immobilization: Strategies for attaching to beads or surfaces for pull-down assays
Cross-linking approaches: Methods to stabilize antibody-antigen complexes
Engineering modifications: Consider recombinant approaches for introducing specific alterations
Emerging single-cell applications include:
Single-cell ChIP-seq adaptations: Modified protocols for low input material
CUT&Tag approaches: For higher sensitivity chromatin profiling
Single-cell imaging: Combining with super-resolution microscopy
Combinatorial indexing strategies: For high-throughput single-cell analysis
Multi-omics integration: Correlating protein localization with transcriptional states
For quantitative applications:
Calibration standards: Develop reference standards for absolute quantification
Interference assessment: Evaluate matrix effects in complex samples
Dynamic range optimization: Match antibody concentration to expected protein levels
Internal controls: Include spike-in controls for normalization
Validation with orthogonal methods: Confirm results using independent quantitative approaches
Statistical analysis frameworks: Apply appropriate models for quantitative interpretation
Important considerations include:
Modification-specific antibodies: Available options for detecting specific PTMs
Epitope masking effects: How modifications may interfere with antibody binding
Confirmation strategies: Methods to verify modification status
Temporal dynamics: Approaches for tracking modification changes over time
Interaction with chromatin: How modifications affect chromatin association patterns
Functional consequences: Connecting modifications to functional outcomes